In addition, we demonstrated that the detectability of NIS-expressing cancer cells and consequently metastasis tracking is greatly enhanced when [18F]BF4−-PET is used as NIS tracer as compared to routine metabolic imaging afforded by [18F]FDG-PET. This evidence concerns the gene SLC5A5 and cancer.